The present invention relates to a combination of a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof which are used as an IAP inhibitor, and an immune checkpoint inhibitor; and use of the combination in the preparation of a cancer treatment drug.
本发明涉及一种由式(I)所表示的化合物、其异构体或其药学上可接受的盐的组合物,其用作IAP
抑制剂,以及免疫检查点
抑制剂的组合物;以及该组合物在制备癌症治疗药物中的应用。